- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03219619
Effect of Cap-assisted Esophagogastroduodenoscopy on Observation of Major Duodenal Papilla
October 18, 2019 updated by: Yanglin Pan, Air Force Military Medical University, China
Effect of Cap-assisted Esophagogastroduodenoscopy on Observation of Major Duodenal Papilla: a Randomized Non-inferiority Trial
Examination of major duodenal papilla (MDP) using a side-viewing duodenoscope is a golden standard.
However, side-viewing duodenoscope is not available in some endoscopic centers.
Cap-assisted esophagogastroduodenoscopy (Ca-EGD) using a transparent cap fitted to the tip of the scope has emerged as an alternative method for the observation of MDP.
A recent study showed that complete examination of MDP could be achieved in 97% of patients.
The investigators hypothesize that Ca-EGD is non-inferior to duodenoscope for the observation of MDP.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Interim analyses were planned to be performed by the data and safety monitoring board after data collection has been completed for 50% of the enrollment.
Study Type
Interventional
Enrollment (Actual)
171
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Chongqing, China, 400010
- Department of gastroenterology, Second Affiliated Hospital of Chongqing Medical University
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710032
- Endoscopic center, Xijing Hospital of Digestive Diseases
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age > 18 years and < 70 years
- Patients with native MDP who underwent ERCP
Exclusion Criteria:
- Prior surgery in upper GI tract
- Prior history of endoscopic sphincterotomy
- Prior history of MDP treatment
- Known or suspected obstruction of upper GI tract
- Patients in poor condition who may not be suitable for Ca-EGD or duodenoscope
- Pregnancy or lactic women
- Inability to give informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cap group: Cap-EGD
Undergoing cap-assisted esophagogastroduodenoscopy
|
Undergoing cap-assisted endoscopy
|
|
Active Comparator: Duo group: Duo
Undergoing side-viewing duodenoscope
|
Undergoing side-viewing duodenoscope
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of complete examination of MDP
Time Frame: 5 minutes after intubation of the esophagus
|
Complete examination is defined by visualization of both proximal and distal ends with orifice of papilla
|
5 minutes after intubation of the esophagus
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Endoscopic findings in descending duodenum
Time Frame: 5 minutes after intubation of the esophagus
|
All pathological findings which are seen in descending duodenum should be reported (e.g.
ampullary adenoma, peripapillary diverticulum, ampullary carcinoma, inflammatory change of papilla, etc)
|
5 minutes after intubation of the esophagus
|
|
Overall endoscopic findings
Time Frame: 5 minutes after intubation of the esophagus
|
All pathological findings which are seen during the examination should be reported (e.g.
reflux esophagitis, gastric cancer, gastric ulcer, duodenal ulcer, etc)
|
5 minutes after intubation of the esophagus
|
|
MDP examination time
Time Frame: 5 minutes after intubation of the esophagus
|
The times taken for the examination of the MDP (after passing the pylorus until examination of MDP)
|
5 minutes after intubation of the esophagus
|
|
MDP examination score
Time Frame: 5 minutes after intubation of the esophagus
|
Score 3 when proximal end, distal end and orifice were visualized; Score 2 when either proximal or distal end with orifice were visualized; Score 1 when either proximal or distal end without orifice was visualized; Score 0 when the MDP could not be localized
|
5 minutes after intubation of the esophagus
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 20, 2018
Primary Completion (Actual)
July 20, 2018
Study Completion (Actual)
July 20, 2018
Study Registration Dates
First Submitted
July 13, 2017
First Submitted That Met QC Criteria
July 13, 2017
First Posted (Actual)
July 17, 2017
Study Record Updates
Last Update Posted (Actual)
October 22, 2019
Last Update Submitted That Met QC Criteria
October 18, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- KY20170517-3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Observation of Major Duodenal Papilla (MDP)
-
Technical University of MunichCompletedDuodenal Papilla, MajorGermany
Clinical Trials on Cap-EGD
-
Washington University School of MedicineTerminated
-
Rutgers, The State University of New JerseyRecruitingGastric CancerUnited States
-
American University of Beirut Medical CenterUnknownAnesthesia, RecoveryLebanon
-
Technical University of MunichUnknownAbdominal PainGermany
-
Midwest Biomedical Research FoundationMedtronic Spine LLCCompletedBarrett EsophagusUnited States
-
Dartmouth-Hitchcock Medical CenterWithdrawnGastro Esophageal Reflux Disease PPI Non-Responders
-
Queen's UniversityCompletedAnemia | Colon PolypsCanada
-
EmuraCenter LatinoAmericaUniversidad de la SabanaCompleted
-
Children's Mercy Hospital Kansas CityUniversity of Kansas Medical CenterCompleted
-
Solventum US LLC3M; Eurotrials Brasil Consultores Cientificos LtdaCompleted